HTG

Pharmaceutical Distribution Platformht-g.jp

Company typePublic
Founded1952
HeadquartersOsaka-shi, Japan
Headcount11–50
GTM typeB2B
OfferingSoftware

HTG firmographics

Firmographics

Name: HTG
Legal name: クリニファー株式会社
Website: https://ht-g.jp
Company type: Public
Founded year: 1952
Operating status: Operating
Headcount range: 11–50 employees
Ownership category
akta.pro rank

HTG industry classification

Industry

Product category: Pharmaceutical Distribution Platform
NAICS: Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC: Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro primary industry: Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)
akta.pro secondary industry: Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

Keywords

Pharmaceutical distribution
Medical product database
B2B pharmaceutical e-commerce
Healthcare supply chain
Prescription medicine sourcing

Where HTG is headquartered

Location

Headquarters

HQ city: Osaka-shi
HQ country: Japan
HQ region: Asia

Offices1 record

Markets served

HTG business model

Business model

GTM type: B2B
Offering type: Software
Cost components: Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Distribution channels2 records

Marketing channels3 records

HTG product offering

Product offering

Core offering

The company distributes prescription pharmaceuticals and medical products between manufacturers and healthcare buyers through two complementary digital platforms. synapse (シナプス) provides an overseas medical pharmaceutical product database enabling Japanese healthcare businesses to source international drugs, while 光成マーケット (Kosei Market) operates as a domestic B2B e-commerce platform for trading prescription pharmaceuticals among licensed healthcare entities.

Product overview

Cliniphar is a pharmaceutical distribution group offering two distinct digital platforms: synapse provides an overseas-facing database for exported medical products, while 光成マーケット (Kosei Market) serves as a domestic B2B e-commerce platform for medical products in Japan. Together, these products form a comprehensive digital healthcare ecosystem addressing both international pharmaceutical distribution and domestic medical product sales.

Differentiator

Problem solved

Functional benefit

Brands

synapse: 海外向け医療用医薬品データベース (Overseas medical pharmaceutical product database)
光成マーケット (Kosei Market)
COREMED (コアメド)

Products and services

synapse (シナプス) Overseas medical pharmaceutical product database providing Japanese healthcare businesses with access to international pharmaceutical product information for procurement and sourcing decisions.
光成マーケット (Kosei Market) Domestic B2B e-commerce platform enabling licensed healthcare businesses and pharmaceutical distributors to trade prescription medicines and medical products within Japan.

Companies that use HTG

Customer profile

Segments1 record

Ideal customer profiles1 record

HTG technology and API

Technology

Technology focussed Yes

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

HTG partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

HTG competitors and assessment

Company assessment

Broad incumbents

McKesson: Global pharmaceutical distribution and healthcare IT giant operating across North America and Europe. Broad incumbent comparable to Cliniphar in pharmaceutical wholesale and data services, but at vastly larger scale and across broader geographies.
Walgreens Boots Alliance: Global pharmacy-led, health and wellbeing enterprise with wholesale distribution and retail pharmacy operations. Comparable as a broad incumbent that combines distribution, retail, and digital/data services touching prescription pharmaceutical flows.
Cencora: U.S.-based global pharmaceutical distributor (formerly AmerisourceBergen) with extensive wholesale, specialty distribution, and data/analytics offerings. Comparable in pharma distribution plus value-added information services — analogous to what Cliniphar attempts at smaller scale via synapse.
Cardinal Health: Global pharmaceutical and medical product distributor with digital procurement platforms for pharmacies and providers. Comparable to Cliniphar in combining physical distribution with digital ordering and data services, though at much larger scope.
CVS Health: Integrated U.S. healthcare company combining pharmacy retail, PBM services, and prescription drug distribution. Comparable to Cliniphar's vertical ambitions in distribution plus data/IT layers, albeit at vastly larger scale and with different regulatory context.

Direct peers

Medipal Holdings: Largest Japanese pharmaceutical wholesaler, distributing prescription drugs, OTC products, and medical devices nationwide. Directly comparable as a domestic pharma distribution incumbent that also operates digital procurement platforms, competing with Cliniphar's Kosei Market for the same Japanese B2B customer base.
Toho Holdings: Japanese pharmaceutical wholesaler with a strong regional footprint and growing digital ordering platform for pharmacies and medical institutions. Directly comparable in domestic pharma B2B distribution and the use of proprietary e-commerce tools.
Suzuken: Major Japanese pharmaceutical wholesaler with nationwide distribution and digital ordering systems serving pharmacies and hospitals. Closely comparable to Cliniphar in core pharmaceutical distribution, target customers, and channel model.
Alfresa Holdings: One of Japan's 'big four' pharmaceutical wholesalers, distributing ethical drugs, OTC products, and medical supplies through a national network. Comparable to Cliniphar in pharma distribution scale ambition and digital procurement initiatives.

Regional players

Phoenix Group: Leading European pharmaceutical distribution group headquartered in Germany, operating wholesale and pharmacy retail across multiple European countries. Comparable as a regional pharma distributor with both distribution and data services, providing a benchmark for Cliniphar's overseas ambitions via synapse.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

HTG financial estimates

Financial estimate

Revenue estimate

Valuation estimate

HTG leadership team

Management profile

Number of profiles

HTG subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

HTG funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

HTG M&A and investment

M&A and investment

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HTG

What does HTG do?

Is HTG a public or private company?

HTG is a public company. It is classified as public and is currently operating.

When was HTG founded?

HTG was founded in 1952. It employs 11 to 50 people.

Where is HTG based?

HTG is headquartered in Osaka-shi, Japan, in the Asia region.

Who are HTG's main competitors?

Broad incumbents on record are McKesson, Walgreens Boots Alliance, Cencora, Cardinal Health and CVS Health. Direct peers are Medipal Holdings, Toho Holdings, Suzuken and Alfresa Holdings. Phoenix Group is listed as a regional player.

Does HTG have an API?

No public API is recorded for HTG.

What industry is HTG in?

HTG's product category is Pharmaceutical Distribution Platform. Its primary akta.pro industry code is HLAIAJAO, Compounding Ingredient & API Distributors (Pharma Supply), with a secondary code of HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms. Its NAICS code is 424210 and its SIC code is 5122.